Carbacaprazamycins: Chemically Stable Analogues of the Caprazamycin Nucleoside Antibiotics

ACS Infectious Diseases

Volumn 1, Issue 4, 2016, Pages 151-156

  Ichikawa, Satoshi ^a   Yamaguchi, Mayumi ^a   Hsuan, Lee Shang ^a   Kato, Yuta ^a   Matsuda, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

antibiotics; caprazamycins; drug resistance; MraY; peptidoglycan

Indexed keywords

ANTIBIOTIC AGENT; CARBACAPRAZAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

AMINATION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONFORMATIONAL TRANSITION; DIASTEREOISOMER; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; HYDROGENOLYSIS; LIPOPHILICITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; STEREOCHEMISTRY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84969220190     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/id5000376     Document Type: Article

References (44)

1. Rachakonda, S. and Cartee, L. (2004) Challenges in antimicrobial drug discovery and the potential of nucleoside antibiotics Curr. Med. Chem. 11, 775-793 10.2174/0929867043455774
2. Barbachyn, M. R. and Ford, C. W. (2003) Oxazolidinone structure-activity relationships leading to linezolid Angew. Chem., Int. Ed. 42, 2010-2023 10.1002/anie.200200528
3. Raja, A., LaBonte, J., Lebbos, J., and Kirkpatrick, P. (2003) Daptomycin Nat. Rev. Drug Discovery 2, 943-944 10.1038/nrd1258
4. Alder, J. D. (2005) Daptomycin: a new drug class for the treatment of Gram-positive infections Drugs Today 41, 81-90 10.1358/dot.2005.41.2.882660
5. Scott, L. (2013) Fidaxomicin: a review of its use in patients with Clostridium difficile infection Drugs 15, 1733-1747 10.1007/s40265-013-0134-z
6. Fox, G. J. and Menzies, D. (2013) A review of the evidence for using bedaquiline (TMC207) to treat multi-drug resistant tuberculosis Infect. Dis. Ther. 2, 123-144 10.1007/s40121-013-0009-3
7. Rice, L. B. (2006) Unmet medical needs in antibacterial therapy Biochem. Pharmacol. 71, 991-995 10.1016/j.bcp.2005.09.018
8. von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., and Häbich, D. (2006) Antibacterial natural products in medicinal chemistry-exodus or revival? Angew. Chem., Int. Ed. 45, 5072-5129 10.1002/anie.200600350
9. O'Shea, R. and Moser, H. E. (2008) Physicochemical properties of antibacterial compounds: implications for drug discovery J. Med. Chem. 51, 2871-2878 10.1021/jm700967e
10. Payne, D. J., Gwynn, M. N., Holms, D. J., and Pompliano, D. L. (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery Nature Rev. Drug Discovery 6, 29-40 10.1038/nrd2201
11. Talbot, G. H., Bradley, J., Edwards, J. E., Jr., Gilbert, D., Scheld, M., and Bartlett, J. G. (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America Clin. Infect. Dis. 42, 657-668 10.1086/499819
12. Overbye, K. M. and Barrett, J. F. (2005) Antibiotics: Where did we go wrong? Drug Discovery Today 10, 45-52 10.1016/S1359-6446(04)03285-4
13. Monagham, R. L. and Barrett, J. F. (2006) Antibacterial drug discovery-then, now and the genomics future Biochem. Pharmacol. 71, 901-909 10.1016/j.bcp.2005.11.023
14. Walsh, C. (2003) Where will new antibiotics come from? Nature Rev. Microbiol. 1, 65-70 10.1038/nrmicro727
15. Igarashi, M., Nakagawa, N., Doi, N., Hattori, S., Naganawa, H., and Hamada, M. (2003) Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp J. Antibiot. 56, 580-583 10.7164/antibiotics.56.580
16. Igarashi, M., Takahashi, Y., Shitara, T., Nakamura, H., Naganawa, H., Miyake, T., and Akamatsu, Y. (2005) Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins J. Antibiot. 58, 327-337 10.1038/ja.2005.41
17. Isono, K., Uramoto, M., Kusakabe, H., Kimura, K., Izaki, K., Nelson, C. C., and McCloskey, J. A. (1985) Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli J. Antibiot. 38, 1617-1644 10.7164/antibiotics.38.1617
18. Ubukata, M., Kimura, K., Isono, K., Nelson, C. C., Gregson, J. M., and McCloskey, J. A. (1992) Structure elucidation of liposidomycins, a class of complex lipid nucleoside antibiotics J. Org. Chem. 57, 6392-6403 10.1021/jo00050a009
19. Ubukata, M. and Isono, K. (1988) The structure of liposidomycin B, an inhibitor of bacterial peptidoglycan synthesis J. Am. Chem. Soc. 110, 4416-4417 10.1021/ja00221a052
20. Kimura, K., Ikeda, Y., Kagami, S., Yoshihama, M., Suzuki, K., Osada, H., and Isono, K. (1998) Selective inhibition of the bacterial peptidoglycan biosynthesis by the new types of liposidomycins J. Antibiot. 51, 1099-1104 10.7164/antibiotics.51.1099
21. Muroi, M., Kimura, K., Osada, H., Inukai, M., and Takatsuki, A. (1997) Liposidomycin B inhibits in vitro formation of polyprenyl (pyro)phosphate N-acetylglucosamine, an intermediate in glycoconjugate biosynthesis J. Antibiot. 50, 103-104 10.7164/antibiotics.50.103
22. Muramatsu, Y., Fujita, Y., Aoyagi, A., Kizuka, M., Takatsu, T., and Miyakoshi, S. WO 2004/046368 A1.
23. Fujita, Y., Kizuka, M., and Murakami, R. JP 2008-74710.
24. Bouhss, A., Mengin-Lecreulx, D., Le Beller, D., and Van Heijenoort, J. (1999) Topological analysis of the MraY protein catalyzing the first membrane step of peptidoglycan synthesis Mol. Microbiol. 34, 576-585 10.1046/j.1365-2958.1999.01623.x
25. Bouhss, A., Trunkfield, A. E., Bugg, T. D., and Mengin-Lecreulx, D. (2008) The biosynthesis of peptidoglycan lipid-linked intermediates FEMS Microbiol. Rev. 32, 208-33 10.1111/j.1574-6976.2007.00089.x
26. Al-Dabbagh, B., Henry, X., El Ghachi, M., Auger, G., Blanot, D., Parquet, C., Mengin-Lecreulx, D., and Bouhss, A. (2008) Active site mapping of MraY, a member of the polyprenyl-phosphate N-acetylhexosamine 1-phosphate transferase superfamily, catalyzing the first membrane step of peptidoglycan biosynthesis Biochemistry 47, 8919-8928 10.1021/bi8006274
27. Bugg, T. D. H., Lloyd, A. J., and Roper, D. I. (2006) Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins Infect. Dis. Drug Targets 6, 85-106 10.2174/187152606784112128
28. Kimura, K. and Bugg, T. D. H. (2003) Nat. Prod. Rep. 20, 252-273 10.1039/b202149h
29. Hirano, S., Ichikawa, S., and Matsuda, A. (2005) Total synthesis of caprazol, a core structure of the caprazamycin antituberculosis antibiotics Angew. Chem., Int. Ed. 44, 1854-1856 10.1002/anie.200462439
30. Hirano, S., Ichikawa, S., and Matsuda, A. (2007) Development of a highly β-selective ribosylation reaction without using neighboring group participation: total synthesis of (+)-caprazol, a core structure of caprazamycins J. Org. Chem. 72, 9936-9946 10.1021/jo701699h
31. Hirano, S., Ichikawa, S., and Matsuda, A. (2008) Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents Bioorg. Med. Chem. 16, 5123-5133 10.1016/j.bmc.2008.03.020
32. Hirano, S., Ichikawa, S., and Matsuda, A. (2008) Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents Bioorg. Med. Chem. 16, 428-436 10.1016/j.bmc.2007.09.022
33. Ii, K., Ichikawa, S., Al-Dabbagh, B., Bouhss, A., and Matsuda, A. (2010) Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria J. Med. Chem. 53, 3793-3813 10.1021/jm100243n
34. Hirano, S., Ichikawa, S., and Matsuda, A. (2008) Synthesis of caprazamycin analogs and their structure-activity relationship for antibacterial activity J. Org. Chem. 73, 569-577 10.1021/jo702264e
35. Tanino, T., Al-Dabbagh, B., Mengin-Lecreulx, D., Bouhss, A., Oyama, H., Ichikawa, S., and Matsuda, A. (2011) Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors J. Med. Chem. 54, 8421-8439 10.1021/jm200906r
36. Tanino, T., Ichikawa, S., Al-Dabbagh, B., Bouhss, A., and Matsuda, A. (2010) Synthesis and biological evaluation of muraymycin analogues as potential anti-drug-resistant bacterial ACS Med. Chem. Lett. 1, 258-262 10.1021/ml100057z
37. Sajjadi, Z. and Lubell, W. D. (2005) Amino acid-azetidine chimeras: synthesis of enantiopure 3-substituted azetidine-2-carboxylic acids J. Pep. Res. 65, 298-310 10.1111/j.1399-3011.2005.00228.x
38. D'hooghe, M., Dekeukeleire, S., Mollet, K., Lategan, C., Smith, P. J., Chibale, K., and De Kimpe, N. (2009) Synthesis of novel 2-alkoxy-3-amino-3-arylpropan-1-ols and 5-alkoxy-4-aryl-1,3-oxazinanes with antimalarial activity J. Med. Chem. 52, 4058-4062 10.1021/jm9002632
39. Scholl, M., Ding, S., Lee, C. W., and Grubbs, R. H. (1999) Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene ligands Org. Lett. 1, 953-956 10.1021/ol990909q
40. Jiang, H., Li, X., Fan, Y., Ye, C., Romoff, T., and Goodman, M. (1999) 3-(Diethoxyphosphoryloxy)-1,2,3- benzotriazin-4(3H)-one (DEPBT): a new coupling reagent with remarkable resistance to racemization Org. Lett. 1, 91-94 10.1021/ol990573k
41. Dess, D. B. and Martin, J. C. (1983) Readily accessible 12-I-5 oxidant for the conversion of primary and secondary alcohols to aldehydes and ketones J. Org. Chem. 48, 4155-4156 10.1021/jo00170a070
42. Bouhss, A., Crouvoisier, M., Blanot, D., and Mengin-Lecreulx, D. (2004) Purification and characterization of the bacterial MraY translocase catalyzing the first membrane step of peptidoglycan biosynthesis J. Biol. Chem. 279, 29974-29980 10.1074/jbc.M314165200
43. Stachyra, T., Dini, C., Ferrari, P., Bouhss, A., van Heijenoort, J., Mengin-Lecreulx, D., Blanot, D., Biton, J., and Le Beller, D. (2004) Fluorescence detection-based functional assay for high-throughput screening for MraY Antimicrob. Agents Chemother. 48, 897-902 10.1128/AAC.48.3.897-902.2004
44. 3, inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus Antimicrob. Agents Chemother. 45, 1823-1827 10.1128/AAC.45.6.1823-1827.2001